Skip to main content
. 2018 Jan 3;6(2):346–349. doi: 10.1002/ccr3.1351

Table 1.

Demographics data of 33 consecutive patients receiving ECMO with or without hemolysis in a single tertiary ICU from October 2009 to February 2015

Variables Mean (Median), Percentage % (number) Range, (IQR)
Age 44 (48) 13–77 (29–57)
Gender
Male 42.4% (14)
Female 57.6% (19)
Indications of ECMO
Respiratory causes 42.4% (14)
Viral pneumonia 18.2% (6)
Bacterial pneumonia 6.1% (2)
Massive hemoptysis 6.1% (2)
Other respiratory diagnosis 3.0% (1)
Extrapulmonary ARDS 3.0% (1)
Chest injuries 3.0% (1)
Asthma 3.0% (1)
Cardiovascular causes 57.6% (19)
Acute myocardial infarction 6.1% (2)
Myocarditis 9.1% (3)
Severe valvular regurgitation/stenosis 9.1% (3)
Postcardiotomy cardiogenic shock 27.3% (9)
Amniotic fluid embolism 3.0% (1)
Massive pulmonary embolism 3.0% (1)
Severe pulmonary hypertension 3.0% (1)
CRRT while on ECMO 50% (14)a
Mode
VV 33.3% (11)
VA 63.6% (21)
VV converted to VA 3.0% (1)
Clinical signs of hemolysis while on ECMO 6.1% (2)
Bleeding complications (overall) 24.2% (8)
Cannulation site 3.0% (1)
Tracheostomy site 3.0% (1)
Sternotomy site requiring resternotomy 6.1% (2)
Gastrointestinal 3.0% (1)
Hemothorax 9.1% (3)
Number of days on ECMO 8.8 (4.5) 1–37 (2–11)
Wean from ECMO 53.1% (17)b
ICU length of stay (days) 14.0 (11.5) 1–50 (3–16)
Death within ICU 48.5% (16)
Hospital deathc 48.5% (16)
Hemolysisd 6.1% (2)
CO‐Hb <3% 0% (0)
CO‐Hb >3% 100% (2)
Without Hemolysise 93.9% (31)
CO‐Hb <3% 96.8% (30)
CO‐Hb >3% 3.2% (1)

IQR, interquartile range; ECMO, extracorporeal membrane oxygenation; ARDS, acute respiratory distress syndrome

a

CRRT after ECMO; CRRT is provided after ECMO is initiated, five patients’ data are missing.

b

Wean from ECMO; liberation from ECMO without death in the next 7 days and second run ECMO, one patient's data are missing.

c

Hospital death; death before hospital discharge to home or a convalescent hospital.

d

Hemolysis; plasma‐free Hb >50 mg/dL.

e

Without Hemolysis; plasma‐free Hb <50 mg/dL.